Novo misses in Alzheimer's trial; Insurer shares rise on report Trump will unveil health policy proposal; Bayer’s stroke drug succeeds in late-stage trial.

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...

U.S. stock futures were flat and international equities mixed amid further signs of returning calm after last week’s ...